Funded Project Details - FY2021
|Title:|| Role of ARF6 in atherosclerotic burden and severity|
Lisa A. Lesniewski
||Salt Lake City, UT
|Congressional District Code:
||Biomedical Laboratory R&D
|| October 2019 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Approximately 92 million US adults have at least one form of cardiovascular disease (CVD), with the annual direct health care cost of CVD and stroke estimated to exceed $315 billion. Among US Veteran’s, CVD is the leading cause of hospitalizations and a major cause of disability and according to the VA Health Services Research and Development, ~80% of Veteran’s present with more than two CVD risk factors. Atherosclerotic diseases are a predominate form of CVD. The severity and associated morbidi...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.